Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection

Alison J Rodger, Zoe Fox, Jens Lundgren, Lewis H Kuller, Christoph Boesecke, Daniela Gey, Athanassios Skoutelis, Matthew Bidwell Goetz, Andrew N Phillips, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group